Equities analysts forecast that Global Medical REIT Inc (NYSE:GMRE) will announce $0.23 earnings per share (EPS) for the current fiscal quarter, Zacks Investment Research reports. Three analysts have issued estimates for Global Medical REIT’s earnings, with estimates ranging from $0.21 to $0.25. Global Medical REIT posted earnings of $0.17 per share in the same quarter last year, which indicates a positive year-over-year growth rate of 35.3%. The business is scheduled to announce its next earnings results on Thursday, November 8th.

On average, analysts expect that Global Medical REIT will report full year earnings of $0.82 per share for the current year, with EPS estimates ranging from $0.78 to $0.89. For the next fiscal year, analysts anticipate that the company will report earnings of $0.92 per share, with EPS estimates ranging from $0.86 to $1.00. Zacks Investment Research’s earnings per share calculations are a mean average based on a survey of analysts that follow Global Medical REIT.

Global Medical REIT (NYSE:GMRE) last posted its quarterly earnings results on Tuesday, August 7th. The company reported $0.19 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.20 by ($0.01). Global Medical REIT had a net margin of 8.00% and a return on equity of 1.91%. The business had revenue of $13.25 million during the quarter, compared to analysts’ expectations of $12.86 million.

GMRE has been the topic of a number of analyst reports. B. Riley set a $11.00 price target on Global Medical REIT and gave the company a “buy” rating in a research note on Friday, August 10th. Boenning Scattergood restated a “neutral” rating on shares of Global Medical REIT in a research note on Friday, June 29th. Zacks Investment Research downgraded Global Medical REIT from a “buy” rating to a “hold” rating in a research note on Wednesday, July 25th. Robert W. Baird initiated coverage on Global Medical REIT in a research note on Thursday. They issued an “outperform” rating and a $11.00 price target on the stock. Finally, TheStreet upgraded Global Medical REIT from a “d” rating to a “c-” rating in a research note on Friday, June 29th. Two research analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. Global Medical REIT has an average rating of “Buy” and a consensus target price of $10.40.

Shares of Global Medical REIT stock traded down $0.09 during trading on Friday, reaching $8.85. The company’s stock had a trading volume of 130,533 shares, compared to its average volume of 129,509. The company has a debt-to-equity ratio of 1.63, a current ratio of 0.14 and a quick ratio of 0.14. Global Medical REIT has a 12-month low of $6.34 and a 12-month high of $10.05. The company has a market cap of $203.76 million, a PE ratio of 16.39, a price-to-earnings-growth ratio of 1.27 and a beta of 0.54.

The firm also recently declared a quarterly dividend, which was paid on Wednesday, October 10th. Investors of record on Thursday, September 20th were paid a $0.20 dividend. The ex-dividend date was Wednesday, September 19th. This represents a $0.80 dividend on an annualized basis and a dividend yield of 9.04%. Global Medical REIT’s dividend payout ratio (DPR) is presently 148.15%.

Several institutional investors have recently bought and sold shares of GMRE. Bank of New York Mellon Corp raised its holdings in Global Medical REIT by 4.0% during the second quarter. Bank of New York Mellon Corp now owns 184,553 shares of the company’s stock worth $1,635,000 after purchasing an additional 7,143 shares during the last quarter. Schwab Charles Investment Management Inc. raised its holdings in Global Medical REIT by 32.4% during the second quarter. Schwab Charles Investment Management Inc. now owns 37,600 shares of the company’s stock worth $334,000 after purchasing an additional 9,200 shares during the last quarter. Renaissance Technologies LLC raised its holdings in Global Medical REIT by 9.6% during the second quarter. Renaissance Technologies LLC now owns 172,900 shares of the company’s stock worth $1,532,000 after purchasing an additional 15,200 shares during the last quarter. A.R.T. Advisors LLC raised its holdings in Global Medical REIT by 126.4% during the first quarter. A.R.T. Advisors LLC now owns 28,130 shares of the company’s stock worth $195,000 after purchasing an additional 15,703 shares during the last quarter. Finally, Citadel Advisors LLC acquired a new position in Global Medical REIT during the second quarter worth $194,000. Hedge funds and other institutional investors own 41.99% of the company’s stock.

Global Medical REIT Company Profile

Global Medical REIT, Inc operates as a development stage company that intends to develop and manage a portfolio of healthcare real estate assets and properties. The company was founded on March 18, 2011 and is headquartered in Bethesda, MD.

Read More: How to interpret a stock’s beta number

Get a free copy of the Zacks research report on Global Medical REIT (GMRE)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Global Medical REIT (NYSE:GMRE)

Receive News & Ratings for Global Medical REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Medical REIT and related companies with MarketBeat.com's FREE daily email newsletter.